ADMA stock forecast
Our latest prediction for Adma Biologics Inc's stock price was made on the Aug. 23, 2023 when the stock price was at 4.00$.
In the short term (2weeks), ADMA's stock price should underperform the market by -1.70%. During that period the price should oscillate between -7.11% and +4.15%.
In the medium term (3months), ADMA's stock price should underperform the market by -3.92%. During that period the price should oscillate between -29.18% and +12.39%.
Get email alertsCreate a solid portfolio with ADMA
About Adma Biologics Inc
adma is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of primary immune deficiency disease (pidd) and certain infectious diseases. adma's mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases. the target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease, or who may be immune-compromised for medical reasons. adma’s lead product candidate, ri-002, has completed a phase iii clinical trial in patients with pidd and has met the primary endpoint. a bla for ri-002 was accepted by the fda on september 18, 2015. the company has received u.s. patent 9,107,906. for more information, please visit the company's website at www.admabiologics.com.
At the moment the company generates 208M USD in revenues.
On its last earning announcement, the company reported a loss of -0.23$ per share.
The book value per share is 1.12$
Three months stock forecastAug. 23, 2023
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
208M | 27.40% | -16M | -8.00% | -47M | -0.23 | - | - | 224M | 1.12 | - | - | - |